Recent advances in diabetes management include new SGLT2 inhibitors like Canagliflozin with expanded therapeutic benefits for Type 2 Diabetes.
← News
Tech for Good Tech for Good Frontiers
Recent Advances in the Management of Diabetes | Pharmacy Times
3 in 2017 New agents approved
SGLT2 Inhibitors Drug class
Diabetic Nephropathy New indication